151 related articles for article (PubMed ID: 16119035)
21. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ
Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
23. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
Ayres JG; Bateman ED; Lundbäck B; Harris TA
Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
[TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
25. Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment.
Anthracopoulos MB; Papadimitriou A; Panagiotakos DB; Syridou G; Giannakopoulou E; Fretzayas A; Nicolaidou P; Priftis KN
Pediatr Pulmonol; 2007 May; 42(5):465-70. PubMed ID: 17394256
[TBL] [Abstract][Full Text] [Related]
26. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.
Bisgaard H; Gillies J; Groenewald M; Maden C
Am J Respir Crit Care Med; 1999 Jul; 160(1):126-31. PubMed ID: 10390389
[TBL] [Abstract][Full Text] [Related]
27. Short-term growth in asthmatic children using fluticasone propionate.
Visser MJ; van Aalderen WM; Elliott BM; Odink RJ; Brand PL
Chest; 1998 Mar; 113(3):584-6. PubMed ID: 9515828
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children.
Volovitz B; Bilavsky E; Nussinovitch M
J Asthma; 2008 Sep; 45(7):561-7. PubMed ID: 18773327
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of inhaled steroid and cromone treatment in school-age children: a randomized pragmatic pilot study.
Kannisto S; Voutilainen R; Remes K; Korppi M
Pediatr Allergy Immunol; 2002 Feb; 13(1):24-30. PubMed ID: 12000495
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R
Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
[TBL] [Abstract][Full Text] [Related]
31. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
[TBL] [Abstract][Full Text] [Related]
32. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
[No Abstract] [Full Text] [Related]
33. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
Visser MJ; Postma DS; Arends LR; de Vries TW; Duiverman EJ; Brand PL
Am J Respir Crit Care Med; 2001 Dec; 164(11):2073-7. PubMed ID: 11739137
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
[TBL] [Abstract][Full Text] [Related]
35. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate.
Wong JY; Zacharin MR; Hocking N; Robinson PJ
J Paediatr Child Health; 2002 Feb; 38(1):59-62. PubMed ID: 11869402
[TBL] [Abstract][Full Text] [Related]
36. Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy.
Kannisto S; Korppi M; Arikoski P; Remes K; Voutilainen R
Pediatr Res; 2002 Aug; 52(2):258-62. PubMed ID: 12149504
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
Gradman J; Wolthers OD
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635
[TBL] [Abstract][Full Text] [Related]
38. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
[TBL] [Abstract][Full Text] [Related]
39. The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children.
Altintas DU; Karakoc GB; Can S; Yilmaz M; Kendirli SG
Allergol Immunopathol (Madr); 2005; 33(4):204-9. PubMed ID: 16045858
[TBL] [Abstract][Full Text] [Related]
40. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
